Cardiovascular gene therapy: An application of HIF-I α gene;Terapia genowa chorób naczyniowo-sercowych: Wykorzystanie genu HIF-I α

Acta Angiologica

Volumn 14, Issue 4, 2008, Pages 125-130

  Małecki, Maciej ^a   Proczka, Robert ^b   Chmiel, Beata ^b   Kotlarz, Agnieszka ^a   Chorostowska Wynimko, Joanna ^c  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Institute for Tuberculosis and Lung Diseases   (Poland)

Author keywords

Cardiovascular diseases; Gene preparations; Gene therapy; Hipoxia

Indexed keywords

ADENOVIRUS VECTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN VP16;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR GENE THERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ERYTHROPOIESIS; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HYPOXIA; INTERMITTENT CLAUDICATION; ISCHEMIA; LIMB ISCHEMIA; METABOLIC REGULATION; NONHUMAN; REVIEW;

EID: 65349155270     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. www.wiley.com
2. Blaese RM, Culver KW, Miller AD et al (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science, 270: 475-480.
3. Zagórska A, Dulak J (2004) HIF-1 the knowns and unknowns of hypoxia sensing. Acta Biochem Polon, 3: 563-585.
4. Hänze J, Eul BG, Savai R (2003) RNA interference for HIF -1 alpha inhibits its downstream signaling and affects cellular proliferation. Biochemical and Biophysical Research Communications, 312:571-577.
5. Hewiston KS, Schofield CJ (2004) The HIF pathway as a therapeutic target. DDT 9: 704-710.
6. Blagosklonny MV (2004) Antiangiogenic therapy and tumor progression. Cancer Cell, 5: 13-17.
7. Carins RA, Papandreou I, Sutphin PD, Denko NC (2007) Metabolic targeting of hypoxia and HIF 1 in solid tumors can enhance cytotoxic chemotherapy. PNAS, 104: 9445-9450.
8. Semenza GL (2007) Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discovery Today, 12: 853-859.
9. Song X, Liu X, Chi W et al (2006) Hypoxia-incluced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1 alpha gene. Cancer Chemother Pharmacol, 58: 776-784.
10. Maxwell PH (2005) The HIF pathway in cancer. Seminars in Cell & Developmental Biology, 16: 523-530.
11. Ravi R, Mookerjee B, Bhujwalla ZM et al (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Develop, 1: 34-44.
12. Dai S, Huang ML, Hsu CY, Chao KS (2003) Inhibition of hypoxia inducible factor 1 alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys, 55: 1027-1036.
13. Tang Y, Schmitt-Ott K, Qian K, Kagiyama S, Phillips MI (2002) Vigilant vectors: adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-thereatening diseases. Methods, 28: 259-266.
14. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI (2004) Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension, 43: 746-751.
15. Dulak J, Zagórska A, Wegiel B, Lobobda A, Józkowicz A (2006) New Strategies for Cardiovascular Gene Therapy. Regulatable Preemptive Expression of Proangiogenic and Antioxidant Genes. Cell Biochem Biophys, 44: 31-42.
16. Tang Y, Jackson M, Qian K, Phillips I (2002) Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension, 39: 695-698.
17. Wihide ME, Jones WK (2006) Potential therapeutic gene for the treatment of ischemic disease: Ad2/Hypoxia- Inducible Factor-1 alpha (HIF-1)/VP16 enhances B-type natiuretic peptide gene expression via a HIF-1 responsive element. Perspective, 69: 1773-1778.
18. Vincent KA, Shyu K, Luo Y et al (2000) Angiogenesis is induced in a rabbit Model of hindlimb Ischemia by naked DNA encoding an HIF-1a/VP16 hybrid transcription factor. Circulation, 102: 2255-2261.
19. Shyu K, Wang M, Wang B et al (2002) Intramyocardial injection of naked DAN encoding HIF-1α/VP16 hybrid to enhance angigenesis in an acute myocardial infraction model in the rat. Cardiovascular Research, 54: 576-583.